Diabetes care startup BeatO raised $33 million in funds led by Lighrock India

Share via:

Diabetes care startup BeatO raised $33 million in funds led by Lighrock India where HealthQuad, Flipkart Ventures and existing investors including Blume Ventures and Leo Capital also participated.

BeatO offers accessible diabetes care with a focus on those who lack access to medical professionals. The company announced that it would use the new funding to expand its operations, hire top leadership, purchase hardware and software, and increase sales of its goods to more people across the nation. With more than 200 million Indians at risk for developing diabetes, the startup predicts that India will soon surpass China to become the world’s diabetes capital.

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Diabetes care startup BeatO raised $33 million in funds led by Lighrock India

Diabetes care startup BeatO raised $33 million in funds led by Lighrock India where HealthQuad, Flipkart Ventures and existing investors including Blume Ventures and Leo Capital also participated.

BeatO offers accessible diabetes care with a focus on those who lack access to medical professionals. The company announced that it would use the new funding to expand its operations, hire top leadership, purchase hardware and software, and increase sales of its goods to more people across the nation. With more than 200 million Indians at risk for developing diabetes, the startup predicts that India will soon surpass China to become the world’s diabetes capital.

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

MedTech World Partners with NovaX Global for Hong Kong...

MedTech World is partnering with NovaX Global, a key player...

Mangalam Worldwide Reports Robust 46 Percentage growth in FY25...

Mumbai (Maharashtra) , May 2: Mangalam Worldwide Limited...

US stablecoin rules fail in Senate procedural vote

The bill, which was supported by only 49...

Popular

Upcoming Events

IndiaMART Picks Remaining Stake In Livekeeping For INR 27...

SUMMARY IndiaMART InterMESH Limited has completed the buyout of...

Your phone might be hacked and this is the...

Cybersecurity threats continue to grow globally, with mobile...

J&T’s race to the bottom in SEA logistics sparks...

As price wars rage on in the region's...
GFD GFaD GsFD